Orphan Drugs and Rare Diseases Conference

Conference themes
This year's SMi's Orphan Drugs and Rare Diseases Conference will bring together regulatory agencies, pharmaceutical companies, non-profit organisations and orphan drugs developers to construct an agenda that addresses the driving economic factors, policies and issues that will affect the development of orphan drugs globally including commercialisation, policies, reimbursement, and pricing.

Professional congress organizer (PCO)
SMi Group

Notes
Brochure: https://go.evvnt.com/229976-2?pid=4832

Mr. Luda Durneva